Presenting Risk Information in Prescription Drug and Medical Device Promotion
Summary
Draft Guidance
Labeling
This FDA guidance document provides recommendations and regulatory information for the medical device industry. It was issued by the Center for Devices and Radiological Health (CDRH) in collaboration with the Center for Biologics Evaluation and Research (CBER).
Document Details
- Issuing Authority: FDA CDRH/CBER
- Status: Draft
- Topic Area: Labeling
- Date: 2009-05-01
Access the Full Document
Source: U.S. Food and Drug Administration (FDA). This content is provided for informational purposes. Always refer to the official FDA document for the most current version.
Document Details
Document IDFDA-CDRH-PRESENTING-RISK-INFORMATION-IN-PRESCRIPTION-DRUG-A
TypeFDA Guidance
AuthorityFDA CDRH/CBER
Publication Date2009-05-01